Metraipolis › archive › dc_5ddb27674244

Self-reported use of cannabidiol as a substitute or adjunct for approved medications — Europe PMC PMID:41725772

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41725772
DOI
10.3389/fpubh.2026.1720348
License (as archived)
solo-consultazione
Archived
2026-11-06T01:39:49.755Z
SHA-256 of the archived text
f2ac54794b6fa7fa509cc85ff20435c54cc42a14b758dde6516d66532677a262
Stable URL of this page
https://metraipolis.com/documento/dc_5ddb27674244

How to cite

Self-reported use of cannabidiol as a substitute or adjunct for approved medications — Europe PMC PMID:41725772 — Europe PMC (en), https://europepmc.org/article/MED/41725772 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5ddb27674244 (Metraipolis archive dc_5ddb27674244, sha256 f2ac54794b6fa7fa509cc85ff20435c54cc42a14b758dde6516d66532677a262)
BibTeX
@misc{dc5ddb27674244,
  title = {Self-reported use of cannabidiol as a substitute or adjunct for approved medications — Europe PMC PMID:41725772},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41725772},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5ddb27674244; sha256 f2ac54794b6fa7fa509cc85ff20435c54cc42a14b758dde6516d66532677a262},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41725772. Agents can read the archived copy with the MCP tool read_document.